A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
NCT07358546
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG:
Efimosfermin alfa
Sponsor
GlaxoSmithKline